Covaxin

Showing of 1 - 20 from 64 results
Covaxin - Total results - 64
COVID-19: Adverse events seen in 0.18% of those vaccinated, says Centre; India to supply vaccines to 6 countries
India

COVID-19: Adverse events seen in 0.18% of those vaccinated, says Centre; India to supply vaccines to 6 countries

India reported 10,064 new covid-19 cases in the last 24 hours, the lowest single-day spike in seven months. Out of the total cases, active cases further dropped to 2 lakh while recoveries went up to over 1.02 crore

Bharat Biotech receives order for additional 45 lakh vaccine doses of Covaxin from govt
Health

Bharat Biotech receives order for additional 45 lakh vaccine doses of Covaxin from govt

Of the 45 lakh doses, over 8 lakh will be supplied to countries such as Mauritius, Philippines and Myanmar, free of cost as a goodwill gesture

WHO chief says unfair COVID-19 vaccine distribution risks causing 'catastrophic moral failure'
World

WHO chief says unfair COVID-19 vaccine distribution risks causing 'catastrophic moral failure'

Tedros Adhanom Ghebreyesus said one poor country received a mere 25 vaccine doses while over 39 million doses have been administered in nearly 50 richer nations

COVID-19 vaccination: 2.24 lakh inoculated in two days; pandemic's third wave on wane in Delhi, says Satyendar Jain
India

COVID-19 vaccination: 2.24 lakh inoculated in two days; pandemic's third wave on wane in Delhi, says Satyendar Jain

India's COVID-19 case count on Sunday climbed to 1,05,57,985 with 15,144 new cases reported in 24 hours, while the toll rose to 1,52,274 with 181 more succumbing to COVID-19 in 24 hours, said the health ministry

COVID-19 vaccination: 447 recipients across India suffer adverse events post inoculation; how AEFI is tracked, reported
India

COVID-19 vaccination: 447 recipients across India suffer adverse events post inoculation; how AEFI is tracked, reported

With COVID-19 making the immunisation of adults necessary, the Centre has involved cardiologists, neurologists, general physicians, and pulmonologists in the AEFI committees at national, state, and district levels

Over 1.91 lakh healthcare, sanitary workers get COVID-19 vaccine jabs; no cases of post-vaccination hospitalisation, says Centre
India

Over 1.91 lakh healthcare, sanitary workers get COVID-19 vaccine jabs; no cases of post-vaccination hospitalisation, says Centre

The Union health ministry that the programme had been a "success" as no cases of post-vaccination hospitalisation had been reported as of 7 pm on Saturday

Bharat Biotech to pay compensation if Covaxin causes 'severe adverse reaction' in recipients
India

Bharat Biotech to pay compensation if Covaxin causes 'severe adverse reaction' in recipients

The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial mode

COVID-19 vaccination drive set to begin today; will be 'beginning of end' of pandemic, says Harsh Vardhan
India

COVID-19 vaccination drive set to begin today; will be 'beginning of end' of pandemic, says Harsh Vardhan

On the eve of the vaccine rollout, Harsh Vardhan reviewed the preparations and visited the dedicated COVID -19 control room set up in premises of the health ministry

No foreign dignitary at R-Day parade due to COVID-19 crisis; new cases under 20,000 for 7th day
India

No foreign dignitary at R-Day parade due to COVID-19 crisis; new cases under 20,000 for 7th day

In view of the global COVID-19 situation, the Centre has decided not to have a foreign dignitary present at the Republic Day celebrations this year. It will be for the first time in over five decades that there will be no chief guest at the Republic Day parade

Narendra Modi to launch vaccination drive on 16 Jan, says Centre; over 56 lakh doses of Covishield sent to 13 cities
India

Narendra Modi to launch vaccination drive on 16 Jan, says Centre; over 56 lakh doses of Covishield sent to 13 cities

The Union health ministry was also quoted as saying that Modi is likely to launch the Co-WIN app, and interact with vaccine beneficiaries across the country

COVID-19 vaccine shipments speed up ahead of inoculation drive; Delhi schools to reopen for classes 10, 12
India

COVID-19 vaccine shipments speed up ahead of inoculation drive; Delhi schools to reopen for classes 10, 12

Delhi chief minister Arvind Kejriwal said the AAP government will provide coronavirus vaccine free to the people of Delhi if the Centre fails to do so

Ready for vaccine roll-out on 16 Jan, COVID-appropriate behaviour important even after inoculation: Health Ministry
India

Ready for vaccine roll-out on 16 Jan, COVID-appropriate behaviour important even after inoculation: Health Ministry

India's drug regulator has approved two vaccines — Oxford-AstraZeneca's Covishield manufactured by SII and Bharat Biotech's Covaxin— for restricted emergency use and the Centre has said that the vaccine roll out will begin from 16 January.

As India preps for COVID-19 vaccine rollout, Centre says 'no proposal' to indemnify vaccine manufacturers
India

As India preps for COVID-19 vaccine rollout, Centre says 'no proposal' to indemnify vaccine manufacturers

Centre in response to an RTI filed said that it currently has no proposal to indemnify or exempt vaccine manufacturers from any liability in case of serious side-effects/adverse reactions due to inoculation of their vaccines.

COVID-19 vaccination drive to begin from 16 Jan for 3 cr people; Bhopal man's death unrelated to vaccine, says Bharat Biotech
India

COVID-19 vaccination drive to begin from 16 Jan for 3 cr people; Bhopal man's death unrelated to vaccine, says Bharat Biotech

In his address at the inauguration of the 16th Pravasi Bharatiya Divas (PBD) Convention, Modi noted India's image as the "world's pharmacy", and said it is ready with two locally manufactured COVID-19 vaccines to "protect" humanity

Coronavirus News Updates: UK approves Moderna's COVID-19 vaccine, pre-orders 7 mn doses
Health

Coronavirus News Updates: UK approves Moderna's COVID-19 vaccine, pre-orders 7 mn doses

Coronavirus News LIVE Updates: In trials with more than 30,000, the Moderna vaccine offered nearly 95 percent protection from severe COVID-19

AIPSN urges govt to reconsider emergency approval for Covaxin till Phase 3 data is published
India

AIPSN urges govt to reconsider emergency approval for Covaxin till Phase 3 data is published

Either pausing or cancelling approvals is not unheard of, and the CDSCO does have the authority to do so.

Curb spike in COVID-19 cases, Centre tells 4 states; second country-wide vaccination dry run today
India

Curb spike in COVID-19 cases, Centre tells 4 states; second country-wide vaccination dry run today

The drill will be held at three-session sites of 736 districts across 33 states and Union Territories, the health ministry said in a statement. The Union health minister will visit Tamil Nadu on Friday to review preparedness and oversee the dry run

All Covid-19 vaccines from India being developed for storage at 2-8 deg Celsius: DBT Secy
India

All Covid-19 vaccines from India being developed for storage at 2-8 deg Celsius: DBT Secy

Logistics at many stages have been worked out keeping this target temperature in mind to meet storage availability.

Ready for COVID-19 vaccine roll-out within 10 days of approval, says health ministry; Boris Johnson postpones India trip
India

Ready for COVID-19 vaccine roll-out within 10 days of approval, says health ministry; Boris Johnson postpones India trip

Union health secretary Rajesh Bhushn also said that the Centre has not banned the export of any vaccines. The country's drugs regulator had on 3 January approved Oxford-Astrazeneca's COVID-19 vaccine, manufactured in India by Serum Institute of India, and Bharat Biotech's Covaxin for restricted emergency use.

Vaccine cold storage chain doesn't reach everywhere: A key threat to equitable Covid-19 vaccination
World

Vaccine cold storage chain doesn't reach everywhere: A key threat to equitable Covid-19 vaccination

There are public health, moral and ethical reasons to invest in vaccines that can be delivered using non-cold-chain approaches.